Immunoprecise Antibodies Ltd
NASDAQ:HYFT

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
Watchlist
Price: 2.24 USD -2.61% Market Closed
Market Cap: $103.4m

Relative Value

The Relative Value of one HYFT stock under the Base Case scenario is 1.48 USD. Compared to the current market price of 2.24 USD, Immunoprecise Antibodies Ltd is Overvalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HYFT Relative Value
Base Case
1.48 USD
Overvaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

HYFT Competitors Multiples
Immunoprecise Antibodies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
106.2m USD 7.2 -4.9 -6.1 -5.4
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 460.4 5 453.9 1 599.2 3 212.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD 5.4 36 25.5 32.9
US
Danaher Corp
NYSE:DHR
165.5B USD 6.8 47.2 25.3 38.2
CH
Lonza Group AG
SIX:LONN
37.6B CHF 5.4 51.9 39.1 39.1
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD 2.5 31.3 15 22.6
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY 6.3 18.7 18.8 18.8
US
Agilent Technologies Inc
NYSE:A
38.2B USD 5.5 29.3 22.7 27.1
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD 7.3 34.2 24.7 27.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR 6.9 76.6 27.1 44.5